Assignee
STAIDSON BIOPHARMA INC
US·0 granted patents·5 pending applications·0 citations·filing 2022–2023
Top patents by PatentIndex Score
5 records- 0171US2026022184A1Masking polypeptides, activatable novel prodrugs and methods of use thereofSTAIDSON BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0266US2026035426A1Il-15 prodrug and uses thereofSTAIDSON BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0355US2026035464A1Antibodies specifically recognizing b- and t-lymphocyte attenuator (btla) and uses thereofSTAIDSON BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0451US2026015423A1Antibodies specifically recognizing programmed cell death1 ligand 1 and uses thereofSTAIDSON BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0550US2025011448A1Antibodies specifically recognizing tnfr2 and uses thereofSTAIDSON BIOPHARMA INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when STAIDSON BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →